A Case of Clinical Overlap
Options include metoclopramide (restricted to maximum 5 days' use due to risk of neurological side effects), prochlorperazine (which may cause drowsiness and anticholinergic effects), or ondansetron (which can cause constipation and has QT-interval prolongation risks in some patients)
A dashboard that simply counts GLP-1 scripts can easily mix several different stories: subsidised type 2 diabetes treatment, private weight-management use, medicine switching during shortages, migration away from compounded replicas, clinical adoption after new evidence, and out-of-pocket discontinuation
Other primary outcomes included PD motor complications as measured by MDS-UPDRS Part IV in endpoints of included studies, motor experiences of daily living in PD patients as measured by MDS-UPDRS Part II in endpoints of included studies, gastrointestinal adverse events of GLP-1 receptor agonists, including dyspepsia, vomiting, diarrhea, and constipation, as well as general adverse events such as headache and fatigue
